PMC3672178_01
IL concentrations and timing of intraocular treatment in a patient with unilateral lymphoma (Case 8).. a) IL-10, b) IL-6, c) IL-10/IL-6. The vertical axis represents IL levels. Red arrows indicate intraocular treatment in the right eye, and blue diamonds indicate intraocular treatment in the left eye.
pone.0065627.g004.jpg
PMC3672178_01_pone.0065627.g004.jpg
pone-0065627-g004
Interleukin-10, IL-6, and IL-10/IL-6 response to intravitreal treatment is displayed in graph form (Fig. 4a-c).
PMC3672178_02
IL concentrations and timing of intraocular treatment in a patient with bilateral lymphoma (Case 9).. a) IL-10, b) IL-6, c) IL-10/IL-6. The vertical axis represents IL levels. Red arrows indicate intraocular treatment in the right eye, and blue diamonds indicate intraocular treatment in the left eye.
pone.0065627.g005.jpg
PMC3672178_02_pone.0065627.g005.jpg
pone-0065627-g005
Incidentally, after receiving an intraocular injection in February, the patient developed a self-resolving post-injection sterile endophthalmitis in the left eye. Interleukin-10, IL-6, and IL-10/IL-6 response to intravitreal treatment is displayed in graph form (Fig. 5a-c).
PMC3672178_03
IL concentrations and timing of intraocular treatment in a patient with bilateral lymphoma (Case 10).. a) IL-10, b) IL-6, c) IL-10/IL-6. The vertical axis represents IL levels. Red arrows indicate intraocular treatment in the right eye, and blue diamonds indicate intraocular treatment in the left eye.
pone.0065627.g006.jpg
PMC3672178_03_pone.0065627.g006.jpg
pone-0065627-g006
Interleukin-10, IL-6, and IL-10/IL-6 response to intravitreal treatment is displayed in graph form (Fig. 6a-c).